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Haemophilus ducreyi is the etiologic agent of chancroid, a sexually transmitted genital ulcer disease. Kera-
tinocytes are likely the first cell type encountered by H. ducreyi upon infection of human skin; thus, the
interaction between H. ducreyi and keratinocytes is probably important for the ability of H. ducreyi to establish
infection. We have used the HaCaT keratinocyte cell line grown in monolayers and in cocultures with HS27
fibroblasts to investigate H. ducreyi interactions with keratinocytes and the host-cell response to H. ducreyi
infection. Using quantitative adherence and gentamicin protection assays, we determined that approximately
13% of H. ducreyi adhered to HaCaT cell monolayers, while only a small proportion (0.0052%) was intracel-
lular. By transmission electron microscopy, we observed numerous H. ducreyi organisms adherent to but rarely
within HaCaT cells cocultured with fibroblasts. Both live H. ducreyi and purified H. ducreyi lipooligosaccharide
(LOS) induced significant interleukin 8 (IL-8) expression from HaCaT cell-HS27 cell cocultures. However, the
level of IL-8 expression in response to LOS alone was not as pronounced. H. ducreyi LOS was a more potent
inducer of IL-8 from cocultures than Escherichia coli lipopolysaccharide (LPS) at the same concentration,
suggesting a unique effect of H. ducreyi LOS on cocultures. Neither live H. ducreyi nor purified H. ducreyi LOS
or E. coli LPS induced tumor necrosis factor alpha expression from cocultures. H. ducreyi induced drastically
different cytokine profiles from cocultures than from HS27 or HaCaT cells cultured separately. IL-8 expression
by skin cells in response to H. ducreyi infection in vivo may be responsible for the massive influx of polymor-
phonuclear leukocytes and other inflammatory cells to the site of infection. This influx of inflammatory cells
may be partly responsible for the tissue destruction characteristic of chancroid.
Haemophilus ducreyi is the gram-negative bacterium respon-
sible for causing the sexually transmitted genital ulcer disease
chancroid (29). Chancroid is prevalent in Southeast Asia and
Africa and is uncommon in the United States, with the inci-
dence of reported cases decreasing from 3,476 in 1991 to only
243 in 1997 (9a). The finding that chancroid is a risk factor for
increased transmission of human immunodeficiency virus (25,
30, 36, 37, 39, 62) has prompted further study into the mech-
anisms by which H. ducreyi causes chancroid in the hope of
discovering ways to prevent chancroid.
The genital ulcer caused by H. ducreyi begins with the entry
of the organism through tiny breaks in keratinized skin (12, 17,
53). A papular lesion that is characterized by a disorganization
of the epidermal layer and an infiltration of polymorphonu-
clear leukocytes (PMN) develops (15, 53). Within several days,
a pustule forms and ruptures, leaving an ulcer that contains
necrotic tissue, PMN, macrophages, and CD41 T cells but few
B cells (52, 53). Although a humoral immune response to H.
ducreyi infection occurs as the disease progresses to the ulcer-
ative stage (10), there is no documented immunity to reinfec-
tion with H. ducreyi in natural infection.
Despite recent research efforts, little is known regarding the
H. ducreyi-specific factors responsible for ulcer formation in
humans. Several putative virulence determinants have been
identified; these include lipooligosaccharide (LOS) (3, 8, 16),
pili (1, 6, 9, 51), a hemolysin (32, 33, 35, 59), a secreted toxin
(11, 22, 23, 41), an outer membrane hemoglobin binding pro-
tein (13, 56), and a copper-zinc superoxide dismutase (46, 55).
However, the molecules involved in the ability of H. ducreyi to
directly interact with host cells and the host cells with which H.
ducreyi associates remain largely unknown.
Several in vitro models that utilize dermal foreskin fibro-
blasts (2, 4, 24) or primary keratinocytes (7, 16, 58) grown as
monolayers have been developed to study H. ducreyi adherence
to and entry into host cells. Although it is clear that H. ducreyi
is capable of adhering to both cell types in vitro (2, 4, 7, 16, 24,
58), whether the organism is intracellular (16, 24, 58) or re-
mains extracellular (2, 4) is controversial. Analyzing H. ducreyi
interactions with individual cell types grown in monolayers is
convenient but may not accurately reflect the in vivo situation,
as skin contains both fibroblasts and keratinocytes in a highly
ordered structure. Recently, using an in vitro skin model (Ad-
vanced Tissue Sciences, La Jolla, Calif.) consisting of a lower
layer containing dermal fibroblasts grown in a collagen matrix
and an upper, epidermis-like layer containing stratified, differ-
entiated keratinocytes, we observed H. ducreyi adherent to
keratinocytes and occasionally within suprabasal keratinocytes
(19). In this in vitro skin model (19), H. ducreyi induced the
secretion of interleukin 8 (IL-8) and IL-6 but not tumor ne-
crosis factor alpha (TNF-a). Since IL-8 is a potent chemoat-
tractant for neutrophils, its induction by H. ducreyi in the in
vitro skin model may mimic an important early event in natural
infection. IL-8 is also expressed in lesions of experimentally
infected human volunteers (34).
We continue to be interested in examining the interaction
between H. ducreyi and keratinocytes on the premise that ker-
atinocytes may be one of the first cell types encountered by H.
ducreyi during natural infection. Literature regarding the in-
teraction between H. ducreyi and keratinocytes is limited. High
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cost and infrequent availability of the in vitro skin model pre-
clude its use in large-scale quantitative analyses of H. ducreyi
adherence and entry. Although primary keratinocytes may be
an ideal cell type for the analysis of H. ducreyi-host cell inter-
actions, human foreskin can be difficult to obtain, tissue char-
acteristics may differ from donor to donor, keratinocyte isola-
tion is time-consuming, and primary keratinocytes are slow
growing. For these reasons, we used the HaCaT keratinocyte
cell line for our studies.
HaCaT cells are spontaneously transformed human adult
skin keratinocytes that were selected for immortality by prop-
agation under low-Ca21 conditions and an elevated tempera-
ture (38°C) (5). In contrast to other transformed keratinocyte
cell lines, HaCaT cells retain the ability to express keratinocyte
differentiation-specific markers and are not tumorigenic when
transplanted onto nude mice (5). Furthermore, the growth of
HaCaT cells to confluence on tissue culture plastic, on collagen
I matrices, and in cocultures with fibroblasts induces differen-
tiation-specific markers, such as the adult skin suprabasal kera-
tins 1 and 10 and the foreskin, neonatal skin, and mucosal
epithelium suprabasal keratins 4 and 13 (45, 48). HaCaT cells
have been used to study aspects of H. ducreyi (26), Streptococ-
cus pyogenes (44, 61), Staphylococcus aureus (14), and herpes
simplex virus (57) infections in vitro. Furthermore, HaCaT
cells, like normal keratinocytes, are capable of expressing a
number of cytokines in response to bacterial pathogens (14, 44,
61) and other perturbations (28).
In this study, we examined the interaction between H. du-
creyi and HaCaT cells in monolayer cultures. Furthermore, we
constructed an in vitro skin-like model consisting of dermal
fibroblasts and HaCaT cells and used it to examine H. ducreyi
adherence to and entry into host cells quantitatively and mi-
croscopically and to examine the host cell cytokine response to
H. ducreyi colonization. Since H. ducreyi LOS has been impli-
cated as a mediator of ulcer formation in some animal models
(8, 16), we also used the coculture system to investigate the
role of LOS in the induction of cytokine expression by host
cells.
MATERIALS AND METHODS
Cell cultures. Cell cultures were maintained at 35°C in a humidified atmo-
sphere with 5% CO2, and medium was replaced every third day or as needed.
The HaCaT keratinocyte cell line (5) was a gift from Bernard Weissman
(Lineberger Comprehensive Cancer Center, University of North Carolina,
Chapel Hill) and was cultured in RPMI 1640 medium (Gibco, Grand Island,
N.Y.) supplemented with 20 mM HEPES and 10% fetal bovine serum (FBS;
Gibco) (RPMI-10). With the addition of FBS, the final calcium concentration in
the medium would be greater than 0.9 mM, a concentration expected to induce
full differentiation of HaCaT cells in cultures (45). Human foreskin fibroblasts
(HS27; American Type Culture Collection, Manassas, Va.; 1634-CRL) were
cultured in Dulbecco’s modified Eagle medium with high glucose (Gibco) and
supplemented with 20 mM HEPES and 10% FBS (DMEM-10).
HS27 cell-HaCaT cell cocultures were constructed as follows. HS27 cells (105)
were seeded on 3-mm collagen I-coated tissue culture inserts in 24-well tissue
culture dishes (Becton Dickinson, Bedford, Mass). HS27 cells were grown for 9
to 11 days in DMEM-10 supplied above and below the insert. HaCaT cells were
seeded on top of the HS27 cells, and the cocultures were grown in RPMI-10
supplied above and below the insert for an additional 9 to 11 days before use in
experiments. For some experiments (see below), HS27 or HaCaT cells were
cultured separately on tissue culture inserts for 9 to 11 days in DMEM-10 or
RPMI-10, respectively.
Bacterial cultures and inoculation protocols. H. ducreyi 35000 (ATCC 33922)
was cultured (i) on chocolate agar plates consisting of 2.5% brain heart infusion
(BHI), 1.5% agar, and 1% hemoglobin (Difco Laboratories, Detroit, Mich.) plus
1% IsoVitaleX (Becton Dickinson, Cockeysville, Md.) and 10% FBS or (ii) in
BHI (3.79%) broth supplemented with 1% IsoVitaleX and 50 mg of hemin
(Sigma, St. Louis, Mo.) per ml at 35°C in 5% CO2. As a negative control for
adherence and entry experiments, we used Escherichia coli ORN200, which was
a gift from Paul Orndorff (College of Veterinary Medicine, North Carolina State
University, Raleigh). ORN200 is a nonpiliated E. coli strain that adheres mini-
mally to but does not enter epithelial cells. ORN200 was grown on Luria-Bertani
(LB) agar plates or in LB broth at 37°C.
H. ducreyi was recovered from freezer stocks on one chocolate agar plate 24 h
before each experiment. On the day of the experiment, the overnight H. ducreyi
growth was suspended in 1 ml of BHI broth and vortexed vigorously for 10 s, and
clumps were allowed to settle for 5 min. Bacteria in the supernatant were
resuspended in 10 ml of BHI broth to approximately 2.5 3 108 CFU/ml and were
grown to approximately 109 CFU/ml (plate counts were determined for each
experiment) at 35°C on a rotary shaker set at 100 rotations per min. One milliliter
of broth culture was removed and vortexed for 10 s, and clumps were allowed to
settle for 5 min before H. ducreyi in the supernatant was resuspended to 106
CFU/ml in RPMI-10 or DMEM-10 for infection of HS27 cells. A 500-ml portion
of this suspension (;5 3 105 CFU) was inoculated onto HaCaT cells grown in
monolayers, HS27 or HaCaT cells grown separately on tissue culture inserts, or
HS27 cell-HaCaT cell cocultures, and the cultures were incubated at 35°C with
5% CO2 for various times. With this inoculation protocol, a multiplicity of
infection (MOI) of between 1 and 5 bacteria per HaCaT cell in monolayer
cultures was achieved. Since we could not remove intact cells from the collagen
substratum, an accurate MOI could not be calculated when cells were cultured
separately or in cocultures on the tissue culture inserts. E. coli ORN200 was
grown in LB broth overnight, diluted 1:100 on the morning of the experiment,
grown to the mid-log phase, resuspended in RPMI-10 to 106 CFU/ml, and
inoculated onto HaCaT cell monolayers or HS27 cell-HaCaT cell cocultures as
described above.
Quantitative adherence and gentamicin protection assays. HaCaT cells (5 3
104 cells/well) were seeded in four-well dishes (Nunc, Rochester, N.Y.) and
grown to confluence (;5 3 105 cells/well). H. ducreyi or E. coli ORN200 was
adsorbed to HaCaT cells for 2 h, and the total CFU present in two wells after 2 h
was determined by collecting the contents of the wells (inoculum plus HaCaT
cells) and plating serial dilutions on chocolate agar or LB agar plates in dupli-
cate. HaCaT cells were removed from the tissue culture plastic by scraping with
sterile wooden sticks. To determine the number of H. ducreyi or E. coli bacteria
adherent to HaCaT cells after 2 h, we removed the nonadherent bacteria in two
wells by washing infected HaCaT cells five times with phosphate-buffered saline
(PBS). We collected the washed HaCaT cells plus associated bacteria and plated
dilutions in duplicate. The percentage of bacterial adherence to HaCaT cells is
expressed as the number of cell-associated bacteria per well at 2 h divided by the
total number of bacteria per well at 2 h, multiplied by 100. Adherence kinetics
were determined similarly, except that H. ducreyi was adsorbed to HaCaT cells
for 0.5, 1, 2, 3, or 4 h before harvest and dilutions were plated to determine the
percentage of H. ducreyi adherent to HaCaT cells at each time point. As ob-
served by light and electron microscopy, H. ducreyi adhered to HaCaT cells
predominantly as individual cells during the adsorption times of the adherence
assays.
Gentamicin protection assays (54) and electron microscopy were used to
determine if H. ducreyi invaded HaCaT cells. After H. ducreyi or E. coli was
adsorbed to HaCaT cells for 2 h, we incubated two wells of HaCaT cells plus
associated bacteria with 100 mg of gentamicin (Gibco) per ml in RPMI-10 for 2 h
to kill extracellular bacteria. This concentration of gentamicin kills 100% of 108
H. ducreyi and E. coli organisms within 2 h (data not shown). Dead bacteria and
antibiotic were removed by washing the HaCaT cells five times with PBS. The
HaCaT cells containing bacteria protected from gentamicin were removed from
the wells as described above for adherence assays, pelleted in a microcentrifuge,
and plated on the appropriate media. The percentage of bacteria protected from
gentamicin was determined by dividing the number of bacteria recovered per
well after gentamicin exposure by the number of bacteria present before genta-
micin exposure, multiplied by 100.
Two modifications of the gentamicin protection assay were used to determine
whether H. ducreyi protected from gentamicin replicated inside HaCaT cells
following 2 h of antibiotic exposure. In one experiment, infected HaCaT cells
were exposed for 2 h to gentamicin; then, the antibiotic was removed and
replaced with fresh RPMI-10. At 24 and 48 h post-gentamicin removal, the entire
contents of the wells were harvested, dilutions were plated, and the number of
bacteria per well was calculated. To determine if the bacteria present at 24 and
48 h were gentamicin accessible, we added gentamicin back to the cultures for 2 h
prior to harvesting the well contents and plating. In a second experiment, gen-
tamicin was incubated with infected HaCaT cells for 2, 4, 8, 24, and 48 h prior to
the harvesting of well contents and plating.
TEM. For transmission electron microscopy (TEM), H. ducreyi was inoculated
onto the apical surface of HS27 cell-HaCaT cell cocultures. After 2, 4, 8, 24, 48,
or 72 h, the nonadherent bacteria were removed with one wash in PBS, and the
cells were fixed in 2.5% glutaraldehyde in 0.15 M sodium phosphate buffer (pH
7.6) for processing for TEM as previously described (38). Mock-infected cocul-
tures served as controls for comparison. Sections were cut, and specimens were
viewed with an EM910 electron microscope (LEO Electron Microscopy, Thorn-
wood, N.Y.).
LOS preparation. H. ducreyi LOS was purified by the method of Westphal and
Jann (63) and was resuspended in endotoxin-free water (Sigma). E. coli lipo-
polysaccharide (LPS) from strain J5 (rough LPS) was purchased from Sigma
(L7520) and was resuspended in endotoxin-free water. Rough E. coli LPS was
chosen for comparison with H. ducreyi LOS (see cytokine experiments below)
because it more closely resembles H. ducreyi LOS than smooth LPS in structure.
The molar concentrations of LOS and LPS in LOS and LPS preparations and
whole H. ducreyi organisms were determined by the 2-keto-3-deoxyoctonate
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assay (20). All LOS and LPS preparations contained ,5% protein, as deter-
mined with the Bradford protein assay reagent (Bio-Rad, Hercules, Calif.) (data
not shown).
Cytokine assays. HS27 cell-HaCaT cell cocultures were inoculated with either
live H. ducreyi, as described earlier, purified H. ducreyi LOS, or E. coli LPS. To
analyze H. ducreyi-induced cytokine expression by HS27 or HaCaT cells, the cells
were cultured separately on tissue culture inserts prior to being inoculated with
H. ducreyi. As a control for TNF-a assays, cocultures were also inoculated with
live E. coli ORN200. The medium under the filters (subnatant medium) was
removed from the filters and replaced with 1 ml of fresh medium at different
times. Therefore, the cytokine accumulation in the medium at each time point is
indicative of the cytokine expression that occurred since the previous time point.
Samples were frozen at 270°C until assayed for IL-8 or TNF-a by an enzyme-
linked immunosorbent assay (R&D Systems, Minneapolis, Minn.) according to
the manufacturer’s instructions. Samples for IL-8 assays were diluted as high as
1:1,000 in some circumstances. The limits of detection for IL-8 and TNF-a were
31.3 and 15.6 pg/ml, respectively.
Statistical analysis. All statistical analyses were performed with SigmaStat 2.0
(Jandel Scientific). The Mann-Whitney rank sum test was used to compare the
difference between the percentages of H. ducreyi and E. coli ORN200 adherence
to and entry into HaCaT cell monolayers. The Kruskal-Wallis test and Dunn’s
multiple-comparison procedure were used to analyze the differences in H. ducreyi
adherence to HaCaT cell monolayers at different time points in kinetics assays.
Student’s t test was used to compare the differences in cytokine levels between
treated (H. ducreyi, LOS, or LPS inoculated) cells and mock-treated cells, and an
analysis of variance followed by the Tukey test was used for multiple-comparison
analyses of cytokine levels between treated groups.
RESULTS
H. ducreyi adheres to HaCaT keratinocyte monolayers. We
used a quantitative adherence assay to determine if H. ducreyi
adhered to HaCaT cells and to examine the kinetics of H.
ducreyi adherence. We inoculated HaCaT cell monolayers with
H. ducreyi at an MOI of between 1 and 5 and calculated the
percentage of adherent H. ducreyi by dividing the number of
HaCaT cell-associated organisms at 0.5, 1, 2, 3, and 4 h posti-
noculation by the total number of H. ducreyi organisms at each
time point. H. ducreyi adherence to HaCaT cells reached sat-
uration at between 1 and 3 h postinoculation (Fig. 1; P, ,0.05)
and did not increase significantly by 4 h. Thus, a 2-h incubation
was chosen for all subsequent adherence assays. Using the
quantitative adherence assay, we found that of the total bac-
teria present after 2 h, a higher percentage of H. ducreyi
(13.2% 6 1.16%) than of E. coli (0.39% 6 0.10%) adhered to
HaCaT cells (P , 0.001). The results of the quantitative ad-
herence assay and the gentamicin protection assay (see below)
are expressed as means 6 SEM and are from at least five
independent experiments performed in duplicate.
H. ducreyi is protected from gentamicin killing following
adsorption to HaCaT cells. We used a gentamicin protection
assay to quantitate H. ducreyi entry into HaCaT cells. Viable H.
ducreyi organisms possibly representing intracellular bacteria
were routinely recovered following a 2-h exposure to gentami-
cin, whereas viable E. coli was rarely recovered. When calcu-
lated based on the total number of bacteria present per well,
the proportion of H. ducreyi protected from gentamicin
(0.0052% 6 0.00087%) at 2 h was low but was significantly
higher than that of E. coli (0.000063% 6 0.000032%) (P ,
0.001). However, when the percentage of organisms protected
from gentamicin was calculated based on the number of ad-
herent bacteria, there was no difference in the percentages of
H. ducreyi and E. coli protected from gentamicin.
To determine if H. ducreyi protected from gentamicin rep-
licated inside HaCaT cells, we extended the experiment by
following the 2-h gentamicin exposure with incubation in an-
tibiotic-free medium and plating dilutions of the well contents
24 or 48 h later. H. ducreyi replicated from an average of 200
bacteria per well immediately following gentamicin exposure
to between 104 and 105 bacteria per well by 48 h (Fig. 2). H.
ducreyi was recovered from both the supernatant and HaCaT
cell-associated fractions (data not shown). If HaCaT cells plus
associated bacteria were exposed to gentamicin for 2 h at 24 or
48 h following gentamicin removal, no viable H. ducreyi was
recovered (Fig. 2). Furthermore, when infected HaCaT cells
were exposed to gentamicin for 2, 4, 8, 24, and 48 h, the
number of viable organisms recovered decreased with increas-
ing time of gentamicin exposure, reaching zero by 24 h (Fig. 2).
Combined, the results presented in Fig. 2 suggest that organ-
isms protected from gentamicin at 2 h after antibiotic exposure
become accessible to gentamicin within 24 h. It is likely that H.
ducreyi protected from gentamicin was initially intracellular
but was toxic for HaCaT cells, allowing gentamicin eventual
access to the previously protected H. ducreyi.
FIG. 1. Maximum adherence of H. ducreyi 35000 to HaCaT cell monolayers
occurs between 1 and 3 h postinoculation. The results are from five independent
experiments performed in duplicate. Boxes represent data in the 25th and 75th
percentiles; the horizontal line in the boxes represents the median. Error bars
encompass data points in the 5th and 95th percentiles.
FIG. 2. Recovery of H. ducreyi over time following gentamicin removal (bro-
ken line) or upon prolonged gentamicin exposure (solid line). Values are means
6 SEM. Arrows represent times after gentamicin removal when gentamicin was
added back to wells run in parallel for 2 h prior to plating for viable bacteria; zero
bacteria were recovered following this treatment (asterisks). The data are from
two independent experiments performed in duplicate.
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H. ducreyi can be found inside HaCaT cells cocultured with
HS27 fibroblasts by electron microscopy. For TEM examina-
tion of H. ducreyi-host cell interactions, we developed an in
vitro skin-like model (HS27 cell-HaCaT cell cocultures) that
more closely represents the in vivo skin structure than do
keratinocyte monolayers. Primary foreskin fibroblasts (HS27
cells) were cultured on collagen I-coated tissue culture inserts
for 9 to 11 days, HaCaT cells were seeded on top of the
fibroblasts, and the cocultures were grown for another 9 to 11
days. Interestingly, the fibroblasts migrated to the opposite
side of the filter (data not shown). The HaCaT cells stratified,
forming several cell layers that morphologically resembled spi-
nous cells in the suprabasal layer of skin (Fig. 3A). Although
we were unable to localize adult skin suprabasal keratin 10 in
these cocultures, we were able to detect foreskin suprabasal
keratin 13 in immunoblots of coculture lysates as well as in
lysates of HaCaT cells harvested from monolayers and tissue
culture inserts (data not shown). Since the cells remained sub-
merged in media, the HaCaT cells did not fully differentiate to
form a keratinized layer, an important aspect of this model
because H. ducreyi does not infect keratinized skin. Further-
more, the HaCaT cells formed desmosomes and contained
epidermal keratin filaments, structures rarely observed in Ha-
CaT cells grown in monolayers (data not shown) but charac-
teristic of polarized cells (Fig. 3A).
Approximately 5 3 105 H. ducreyi organisms were added to
the surfaces of the cocultures. At 2, 4, 8, 24, 48, and 72 h
postinoculation, nonadherent bacteria were washed away and
the cells were fixed and processed for electron microscopy.
Individual H. ducreyi organisms were found closely associated
with the HaCaT cell surface 2 h postinoculation (data not
shown) and throughout the time course (Fig. 3B). H. ducreyi
was not found in association with HS27 cells or the collagen
matrix. As bacterial numbers increased over time, we observed
extracellular clumps of H. ducreyi exhibiting the characteristic
“school-of-fish” appearance (29) (Fig. 3C). HaCaT cells near
large numbers of H. ducreyi organisms appeared necrotic. It
was difficult to find H. ducreyi inside HaCaT cells 2 h postin-
oculation, consistent with the low numbers of H. ducreyi or-
ganisms protected from gentamicin at this time. It was easier to
locate intracellular H. ducreyi 24 h or more postinoculation,
although this observation was still rare. Intracellular H. ducreyi
appeared predominantly in vacuoles (Fig. 3D and E) and was
commonly found within dead HaCaT cells within 24 h postin-
oculation (Fig. 3E). H. ducreyi within dead HaCaT cells ap-
peared healthy, as evidenced by the integrity of double mem-
branes surrounding the bacteria. Finding H. ducreyi within
dead HaCaT cells combined with the gentamicin protection
data suggests that prolonged culturing of H. ducreyi-infected
HaCaT cells results in cytotoxicity and subsequent access of
the antibiotic to intracellular organisms.
H. ducreyi induces IL-8 but not TNF-a expression by HS27
cell-HaCaT cell cocultures. We previously showed that H. du-
creyi induced IL-6 and IL-8 but not TNF-a expression from
cells in an in vitro skin model (19). Since we were interested in
whether the HS27 cell-HaCaT cell coculture model responded
similarly to H. ducreyi, we verified that the IL-8 and TNF-a
induction profiles in cocultures mimicked those in the in vitro
skin model.
RPMI-10 containing approximately 5 3 105 H. ducreyi or-
ganisms or RPMI-10 without bacteria was added to the apical
surface of established cocultures. The subnatant medium was
collected and replaced with fresh RPMI-10 at 2, 6, 24, 48, or
72 h postinoculation, and the samples were assayed for both
IL-8 and TNF-a production by an enzyme-linked immunosor-
bent assay (Fig. 4). The patterns of IL-8 and TNF-a expression
of cocultures in response to H. ducreyi were similar to those of
in vitro skin. IL-8 expression levels in H. ducreyi-infected and
uninfected cocultures were indistinguishable 2 and 6 h postin-
oculation. However, by 24 h, cocultures expressed significantly
more IL-8 in response to H. ducreyi than did uninfected cocul-
tures (Fig. 4; P, 0.002). Maximum IL-8 expression occurred by
48 h postinoculation, with no significant increase in expression
by 72 h postinoculation (Fig. 4; P, ,0.05). Consistent with our
earlier finding (19), H. ducreyi-infected cocultures that ex-
pressed IL-8 did not express TNF-a above the limit of detec-
tion of the assay, 15.6 pg/ml, at any time point examined.
However, the cocultures were capable of expressing TNF-a, as
E. coli ORN200 induced detectable levels of TNF-a (62.6 6
9.07 pg/ml) 24 h postinoculation (inoculum of 5 3 105 E. coli
organisms).
To determine if HS27 or HaCaT cells alone exhibited a
cytokine profile similar to that of cocultures in response to H.
ducreyi, HS27 and HaCaT cells were cultured separately on
tissue culture inserts for 9 to 11 days and inoculated with H.
ducreyi. Subnatant medium was assayed for cytokine produc-
tion. HS27 cells produced a large amount of IL-8 24 and 48 h
postinoculation in response to H. ducreyi, whereas HaCaT cells
produced a small but significant amount of IL-8 at these times
(Table 1). TNF-a was not expressed by HaCaT cells inoculated
with H. ducreyi, as was observed with cocultures and the in vitro
skin model. In contrast, H. ducreyi induced a detectable
amount of TNF-a from HS27 cells 24 h postinoculation
(32.8 6 3.72 pg/ml). A direct interaction between H. ducreyi
and HS27 cells may be required for IL-8 and TNF-a expression
from HS27 cells, since filtered medium from H. ducreyi-in-
fected HaCaT cells 24 h postinfection did not induce IL-8 or
TNF-a expression from HS27 cells (data not shown). The fact
that H. ducreyi did not associate with HS27 cells in the cocul-
ture system may account for the lack of TNF-a expression and
the decreased IL-8 expression by cocultures versus HS27 cells
alone in response to H. ducreyi.
H. ducreyi LOS is partially responsible for IL-8 induction in
HS27 cell-HaCaT cell cocultures. LPS and LOS induce IL-8
expression from macrophages (42) and, to some extent, from
epithelial cells (18). Furthermore, LPS and LOS are known to
be potent inducers of TNF-a expression from macrophages
(42) and induce TNF-a from a variety of epithelial cells, in-
cluding keratinocytes (21). We wondered why live E. coli but
not H. ducreyi induced TNF-a expression from cocultures,
even though both organisms contain the minimal LPS or LOS
requirements for bioactivity (50), one aspect of which is the
induction of TNF-a expression (42). Thus, we investigated
whether H. ducreyi LOS in the absence of bacterial proteins
could induce IL-8 and TNF-a expression from HS27 cell-Ha-
CaT cell cocultures.
We added 360, 3.6, or 0.036 nM purified H. ducreyi LOS
(corresponding to approximately 5 3 107, 5 3 105, or 5 3 103
bacteria, respectively) in RPMI-10 to HS27 cell-HaCaT cell
cocultures and assayed the subnatant medium for IL-8 (Fig. 5)
and TNF-a as described above. Consistent with results ob-
tained with live H. ducreyi, 360 nM purified H. ducreyi LOS
induced significantly greater IL-8 expression from cocultures
than that seen in controls 24 and 48 h post-LOS addition (Fig.
5; P, ,0.05). There was no significant IL-8 expression in re-
sponse to LOS 6 h postinoculation. In contrast to the finding
that cocultures expressed more IL-8 by 48 h than by 24 h after
the addition of live H. ducreyi, maximum expression of IL-8 in
response to 360 nM LOS occurred by 24 h postinoculation.
Furthermore, 360 nM LOS did not induce IL-8 expression to
the levels induced by live H. ducreyi (compare the y axes of Fig.
4 and 5). By 24 h, 360 nM H. ducreyi LOS and 360 nM E. coli
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LPS induced IL-8 expression from cocultures; however, H.
ducreyi LOS induced a significantly higher concentration of
IL-8 than did E. coli LPS at this time (Fig. 5; P, ,0.05). H.
ducreyi LOS but not E. coli LPS induced significantly more
IL-8 than that seen in controls by 48 h (Fig. 5). Combined,
these data suggest that H. ducreyi LOS induces a specific re-
sponse from cocultures.
Neither 360 nM H. ducreyi LOS nor 360 nM E. coli LPS
induced TNF-a expression from HS27 cell-HaCaT cell cocul-
tures (data not shown), suggesting either that LPS or LOS is
not the sole mechanism for TNF-a induction in this system or
that the system lacks cell types or molecules necessary for
LOS- or LPS-induced TNF-a expression.
DISCUSSION
The study of H. ducreyi pathogenesis has been hampered by
the scarcity of relevant in vitro models with which to study the
roles of the putative virulence determinants of this obligate
human pathogen. In this report, we describe a coculture model
for examining H. ducreyi adherence to and entry into keratin-
ocytes. In addition, we have used the cocultures to assess the
host cell cytokine response to H. ducreyi infection in an attempt
to begin to understand the inflammatory response to H. ducreyi
infection in vivo.
It is unclear whether H. ducreyi interacts with fibroblasts or
keratinocytes upon introduction into breaks in the skin. We
constructed a coculture system consisting of HS27 dermal fore-
skin fibroblasts grown on a collagen I-coated tissue culture
insert and HaCaT keratinocytes to more closely mimic in vivo
skin structure than keratinocyte monolayers. Collagen I was
used as the growth substrate because it is the most abundant
collagen type in the dermis. Cocultures exhibited the same
cytokine profile in response to H. ducreyi as that of a commer-
cially available in vitro skin system, whereas a different cyto-
kine profile was induced when the cell types were cultured
separately. The commercially available in vitro skin model
used previously in our laboratory was constructed similarly,
except that the cells were fed only from the bottom and the
keratinocytes were exposed to the air, facilitating terminal
differentiation of the keratinocytes and keratinization (19).
Since H. ducreyi does not infect keratinized skin (12, 17, 53), it
was necessary to first abrade the surface of the keratinized
layer of the in vitro skin model to establish H. ducreyi infection.
The fact that our modified coculture model does not require
this step, as the keratinocytes remain submerged in medium
and do not terminally differentiate, adds a particularly attrac-
tive feature to this model.
Using a quantitative adherence assay and TEM, we found
that H. ducreyi 35000 adhered to HaCaT cells cultured in
monolayers and in cocultures with fibroblasts. These data are
consistent with those of previous studies that examined H.
ducreyi adherence to primary keratinocytes grown as monolay-
ers (7, 16, 58), suggesting that HaCaT cells are relevant for
studies of H. ducreyi-keratinocyte interactions. We found that
approximately 13% of H. ducreyi 35000 adhered to HaCaT
cells and that maximum adherence occurred approximately 2 h
postinoculation. Totten et al. (58), using an uncharacterized
strain of H. ducreyi (LA228R), and Brentjens et al. (7), using
H. ducreyi 35000, also found that 2 h was required for maxi-
mum adherence to primary keratinocytes and that 30 to 50%
of H. ducreyi LA228R or 15 to 23% of H. ducreyi 35000 ad-
hered at this time. Gibson et al. (16) also found that 15% of H.
ducreyi 35000 adhered to primary keratinocytes 2 h postinocu-
lation. The significantly higher percentage of H. ducreyi adher-
ence found by Totten et al. (58) may be accounted for by two
facts. First, the H. ducreyi strain used in their study was pas-
saged in the temperature-dependent animal model and might
be more adherent and invasive than the commonly used labo-
ratory strain 35000. Second, the percentage of adherence in
their study was based on the number of H. ducreyi organisms
that adhered versus the input number of H. ducreyi organisms
and thus did not account for replication of the population
during the assay.
Using TEM, we observed H. ducreyi adherent to HaCaT cell
processes or pedestals emanating from the cell surface. Similar
pedestals have also been observed under epithelial cell-adher-
ent enteropathogenic E. coli, and their synthesis requires in-
duction by a bacterial protein and subsequent actin polymer-
ization (43). Cytochalasin D, a potent inhibitor of actin
polymerization, at low concentrations (#5 ng/ml) that did not
cause rounding up of the HaCaT cells, had no effect on H.
ducreyi adherence (data not shown). Higher concentrations of
cytochalasin D ($5 ng/ml) had a severe effect on HaCaT cell
morphology. Thus, the data cannot exclude the possibility that
actin polymerization is important for H. ducreyi adherence.
We found that only 0.005% of H. ducreyi bacteria entered
HaCaT cells in our system, whereas Totten et al. (58) found
that 0.11% of H. ducreyi 35000 entered primary keratinocytes.
The differences observed here may be explained by differences
in experimental protocols or in vitro systems. Nevertheless, the
percentage of H. ducreyi bacteria protected from gentamicin in
FIG. 4. H. ducreyi induces IL-8 expression from HS27 cell-HaCaT cell co-
cultures. Results are expressed as means 6 SEM and were obtained from three
independent experiments performed in triplicate.
FIG. 3. Transmission electron micrographs of H. ducreyi-infected HS27 cell-HaCaT cell cocultures. (A) Uninfected cocultures exhibit healthy cellular morphology.
Layers of HaCaT cells resemble suprabasal layers of keratinocytes in skin characterized by spines (S) that connect individual cells. Well-formed desmosomes (D) and
epidermal filaments (E) are also apparent. Magnification, 34,500; bar, 1 mm. (B) H. ducreyi organisms (Hd) adhere to pedestals on HaCaT cells. The H. ducreyi
membrane and the HaCaT cell membrane are closely associated (arrowhead). This is a representative micrograph taken 24 h postinoculation. Magnification, 336,000;
bar, 1 mm. (C) An H. ducreyi “school of fish” adheres to the remnants of an HaCaT cell membrane 24 h postinoculation. Necrotic (N) HaCaT cells are evident opposite
the large clump of bacteria. Magnification, 31,800; bar, 1 mm. (D) H. ducreyi organisms (arrowheads) are found in vacuoles within HaCaT cells at 24 h postinoculation.
Junctions between cells are disrupted (compare with panel A). Magnification, 37,200; bar, 1 mm. (E) H. ducreyi organisms (arrowheads) are localized inside dead
HaCaT cells (Ha) 24 h postinoculation. Magnification, 34,500; bar, 1 mm.
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our experiments was remarkably low, even though we had little
difficulty locating intracellular bacteria by electron microscopy.
A plausible explanation for this finding is that gentamicin is
able to gain access to the intracellular milieu of HaCaT cells,
killing intracellular H. ducreyi. One likely mechanism by which
this may occur is if H. ducreyi were cytotoxic or caused minor
membrane damage to HaCaT cells. Although H. ducreyi does
not cause the destruction of HaCaT cell layers at least up to
72 h postinoculation (unpublished results), some degree of
cytopathology, such as vacuolation, has been observed by us
(unpublished results) and others (26). H. ducreyi secretes a
cytotoxin (cytolethal distending toxin) that exhibits a cyto-
pathic effect on HaCaT cells (26). Finding necrotic HaCaT
cells in the vicinity of extracellular clumps of H. ducreyi (Fig.
3C) and H. ducreyi within dead HaCaT cells (Fig. 3E) supports
the notion that H. ducreyi is cytotoxic for these cells.
Another possible explanation for why gentamicin may enter
HaCaT cells is that HaCaT cells may be naturally leaky. The
gentamicin protection assay is widely used to quantitate bac-
terial invasion into epithelial cells and is based on the premise
that gentamicin does not enter epithelial cells; thus, intracel-
lular bacteria are protected from gentamicin exposure. How-
ever, it is known that aminoglycoside antibiotics, such as gen-
tamicin, may enter some epithelial cells by endocytosis (47).
Finally, it is possible that H. ducreyi enters only keratinocytes
of a specific differentiation type in vivo, a cell type that may be
present in a small percentage in the HaCaT cell population.
Staining of HaCaT cells with markers for specific stages of
keratinocyte differentiation may help address this issue. The
observation of large numbers of H. ducreyi organisms adherent
to some HaCaT cells but not others is consistent with the
possibility that H. ducreyi exhibits selective cell tropism.
By TEM, we observed intracellular H. ducreyi predominantly
within vacuoles, consistent with the findings of Totten et al.
(58). This location may protect H. ducreyi from a necrotic
environment, an idea supported by the finding of apparently
healthy H. ducreyi bacteria within dead HaCaT cells (Fig. 3E).
It has been suggested that H. ducreyi entry into keratinocytes
may be an important factor in the tissue destruction observed
in chancroid ulcers (58). Although we were able to locate H.
ducreyi organisms within HaCaT cells cultured in the coculture
system by TEM, this finding was rare. Furthermore, we found
more necrotic HaCaT cells associated with adherent, extracel-
lular H. ducreyi than containing intracellular H. ducreyi. These
data suggest that a prolonged intracellular stage may not be a
significant factor in the pathogenesis of H. ducreyi. Other fac-
tors, such as toxins and the inflammatory response, may be
primarily responsible for tissue necrosis in chancroid lesions.
Epidermal cells are important immune mediators, as they
are the first line of defense against invading pathogens. Con-
sistent with our previous study with an in vitro skin model, we
found that IL-8 expression was induced in HS27 cell-HaCaT
cell cocultures in response to H. ducreyi. IL-8 is a chemokine
that is a potent inducer of neutrophil chemotaxis and neutro-
phil activation and is also capable of inducing the chemotaxis
of T cells (31). During natural H. ducreyi infection, neutrophils
accumulate in the ulcer and remain a prominent inflammatory
cell type in the lesion over the duration of the infection (15).
Since neutrophils have a short life span, their continued pres-
ence in the ulcer must be due to the constant taxis of new
neutrophils to the site of H. ducreyi infection. Our findings that
H. ducreyi induces IL-8 expression from cocultures 24 h posti-
noculation, that maximum expression occurs at 48 h, and that
expression continues at that level at least up to 72 h postin-
oculation suggest that the continuous expression of IL-8 may
occur in vivo and may mediate constant PMN chemotaxis and
recruitment of T cells.
H. ducreyi LOS added to cocultures at 360 nM, correlating
with approximately 5 3 107 bacteria, also induced IL-8 expres-
sion 24 h postinoculation. However, the level of IL-8 expres-
sion at 24 h was only half that induced by live H. ducreyi, even
though the number of live H. ducreyi bacteria present 24 h
postinoculation was approximately 5 3 107 (data not shown).
These data suggest that other bacterial components may be
necessary for the maximum induction of IL-8. However, it is
also possible that purified LOS interacts with eukaryotic cells
in a manner different from that of LOS present in the H.
ducreyi membrane. H. ducreyi LOS did not induce increased
IL-8 expression between 24 and 48 h postinoculation, as was
observed for live organisms, suggesting that bacterial replica-
tion or LOS shedding from H. ducreyi during replication may
account for the observed increase in IL-8 expression during
this time frame. The finding that H. ducreyi LOS induced
significantly more IL-8 than E. coli LPS at the same concen-
tration suggests that a unique interaction between H. ducreyi
LOS and cocultured cells may occur. We are currently inves-
tigating the role of H. ducreyi-mediated IL-8 expression in
neutrophil migration to the site of infection and the bacterial
FIG. 5. H. ducreyi LOS is partially responsible for H. ducreyi-induced IL-8
expression from HS27 cell-HaCaT cell cocultures. H. ducreyi LOS (0 to 360 nM)
or E. coli LPS (360 nM) was added to cocultures, and subnatant medium was
removed and replaced with 1 ml of fresh medium. Results are expressed as
means 6 SEM and were obtained from four independent experiments per-
formed in duplicate.
TABLE 1. IL-8 expression by HS27 or HaCaT cells in
response to H. ducreyi
Cell line Inducer
Mean amt (6 SEM) of IL-8
expressed (pg/ml) at:
24 h 48 h
HaCaT Mock 328.8 6 37.8 189.0 6 36.7
H. ducreyi 530.1 6 10.7a 541.5 6 53.8b
HS27 Mock 56.6 6 14.0 70.3 6 35.5
H. ducreyi 144,0006 19,000c 255,000 6 24,000a
a P value for comparison with control (mock), 0.002.
b P value for comparison with control, 0.014.
c P value for comparison with control, 0.007.
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factors responsible for IL-8 induction. The results of these
experiments will provide information about the events occur-
ring early during H. ducreyi infection.
TNF-a is an important inflammatory mediator that is in-
duced, among other ways, in response to gram-negative bac-
terial pathogens upon stimulation of macrophages with LPS
(42). Surprisingly, H. ducreyi did not induce TNF-a expression
from cocultures or the in vitro skin system, whereas E. coli did.
This result was unexpected, since the LOS of H. ducreyi con-
tains all of the structural requirements necessary to induce
TNF-a expression (42, 50). Even more surprising was our
finding that purified E. coli LPS did not induce TNF-a from
cocultures, even when present at levels higher than those phys-
iologically necessary to induce TNF-a from macrophages.
Higher levels of E. coli LPS (100 mg) have been found to
induce TNF-a expression from keratinocytes (21); however, we
chose to use physiologically relevant LPS levels for our studies.
Our findings suggest that LPS is not the mediator of E. coli-
induced TNF-a expression in the coculture system. The TNF-a
expression observed in cocultures in the presence of whole E.
coli may be due to the fact that E. coli begins to kill cells in
cocultures 24 h postinoculation, and HaCaT cellular lysis has
been shown to trigger TNF-a expression (14). Another possi-
ble explanation is that E. coli, unlike H. ducreyi, is capable of
gaining access to fibroblasts in cocultures, eliciting a TNF-a
response by these cells. The finding that H. ducreyi induces
TNF-a from HS27 cells cultured separately suggests that if H.
ducreyi were capable of directly interacting with HS27 cells in
cocultures, a TNF-a response might be elicited.
LOS- or LPS-mediated TNF-a expression requires either
the CD14 cellular receptor (64) or the soluble form of this
receptor (sCD14) (40) plus a serum protein, LPS binding pro-
tein (LBP) (49). LBP binds to LOS or LPS and transports LOS
or LPS to either sCD14 in serum or CD14 on the cell surface,
which interacts with another unknown receptor responsible for
initiating signal transduction events, leading to TNF-a expres-
sion (60). Most human epithelial cells do not express CD14 but
can still be stimulated with LOS or LPS to express TNF-a if the
culture medium contains serum that has sCD14 and LBP (40),
both of which can be supplied by FBS (used in our studies) but
are not as active as their human counterparts (27). One reason
for the absence of a TNF-a response in our coculture system
may be that the HS27 or HaCaT cells do not express CD14
and/or that the serum does not contain active sCD14 or LPB.
We are currently investigating these possibilities.
In conclusion, we have developed a new in vitro model with
which to study H. ducreyi-host cell interactions and the host cell
immune response to H. ducreyi. The coculture described in this
report represents a relevant system that will be useful for
examining potential virulence factors of H. ducreyi that are
responsible for ulcer formation. Furthermore, this system will
enable us to examine the role of H. ducreyi products that are
responsible for the host cell cytokine response to infection.
Since the system is amenable to the addition of inflammatory
cells, such as PMN, we will be able to examine mechanisms of
immune cell chemotaxis to infected keratinocytes in vitro and
may gain insight into events that occur early in natural H.
ducreyi infection. The results of these experiments will provide
a basis for an understanding of the epithelial and neutrophil
immune responses to H. ducreyi infection and insight into ways
to modify the immune response to efficiently clear infection.
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